XIAP and colorectal cancer: As the first peptide that targets the survivin-XIAP complex, Sur-X was proved to be able to interfere with survivin-XIAP interaction, promote ubiquitination-mediated degradation of survivin and XIAP, and hence induce Caspase 9-dependent intrinsic apoptosis in colorectal cancer cells.